Skip to content

Clinical trials

Phase 1/2 trials in Peru

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 1/2 Country / region: Peru Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20091
20102
20121
20131
20182
20201
20221
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated2
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Merck Sharp & Dohme LLC2
Antiva Biosciences1
Boston Pharmaceuticals1
Bristol-Myers Squibb1
Kezar Life Sciences, Inc.1
National Institute of Allergy and Infectious Diseases (NIAID)1
Sanofi1
University of Colorado, Denver1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms2
Lupus Erythematosus, Systemic2
Neoplasm Metastasis2
Altitude Sickness1
Carcinoma, Non-Small-Cell Lung1
HIV Infections1
Hematologic Neoplasms1
Lupus Nephritis1
Meningitis1
Meningitis, Cryptococcal1

Trials

Showing 51 to 12 of 12. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.